# Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

> **NCT03682640** · PHASE2 · UNKNOWN · sponsor: **Uppsala University** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus
- Metabolic Disease
- Glucose Metabolism Disorders
- Endocrine System Diseases
- Juvenile Diabetes
- Insulin Dependent Diabetes
- Type 1 Diabetes Mellitus
- Inflammation
- Diet Modification

## Interventions

- **DRUG:** Azithromycin Monohydrate
- **DRUG:** Insulin Lispro
- **BEHAVIORAL:** Dietician support

## Key facts

- **NCT ID:** NCT03682640
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682640, "Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03682640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*